🟢 Moleculin Biotech is trading 6.38% up in pre-market — no company-specific catalyst identified

Moleculin Biotech is trading 6.38% up in pre-market at $0.65, after rising from the August 25 close of $0.61; no new company-specific announcement or overnight catalyst was identified for August 26, 2026.

• Latest notable developments include the August 14 quarterly update and previously reported positive MIRACLE trial data.
• A recent Zacks upgrade may support sentiment but does not clearly explain this pre-market move.